Niza, E.; Noblejas-López, M.d.M.; Bravo, I.; Nieto-Jiménez, C.; Castro-Osma, J.A.; Canales-Vázquez, J.; Lara-Sanchez, A.; Galán Moya, E.M.; Burgos, M.; Ocaña, A.;
et al. Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer. Nanomaterials 2019, 9, 1793.
https://doi.org/10.3390/nano9121793
AMA Style
Niza E, Noblejas-López MdM, Bravo I, Nieto-Jiménez C, Castro-Osma JA, Canales-Vázquez J, Lara-Sanchez A, Galán Moya EM, Burgos M, Ocaña A,
et al. Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer. Nanomaterials. 2019; 9(12):1793.
https://doi.org/10.3390/nano9121793
Chicago/Turabian Style
Niza, Enrique, MarÃa del Mar Noblejas-López, Iván Bravo, Cristina Nieto-Jiménez, José Antonio Castro-Osma, Jesús Canales-Vázquez, AgustÃn Lara-Sanchez, Eva M. Galán Moya, Miguel Burgos, Alberto Ocaña,
and et al. 2019. "Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer" Nanomaterials 9, no. 12: 1793.
https://doi.org/10.3390/nano9121793
APA Style
Niza, E., Noblejas-López, M. d. M., Bravo, I., Nieto-Jiménez, C., Castro-Osma, J. A., Canales-Vázquez, J., Lara-Sanchez, A., Galán Moya, E. M., Burgos, M., Ocaña, A., & Alonso-Moreno, C.
(2019). Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer. Nanomaterials, 9(12), 1793.
https://doi.org/10.3390/nano9121793